Efficacy and Safety of a Single Dose of Ivermectin, Diethylcarbamazine, and Albendazole for Treatment of Lymphatic Filariasis in Côte d’Ivoire: An Open-label Randomized Controlled Trial

BACKGROUND: Improved drug regimens are needed to accelerate elimination of lymphatic filariasis in Africa. This study determined whether a single co-administered dose of ivermectin plus diethylcarbamazine plus albendazole [IDA] is noninferior to standard 3 annual doses of ivermectin plus albendazole...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Infect Dis
Auteurs principaux: Bjerum, Catherine M, Ouattara, Allassane F, Aboulaye, Méité, Kouadio, Olivier, Marius, Vanga K, Andersen, Britt J, Weil, Gary J, Koudou, Benjamin G, King, Christopher L
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2019
Sujets:
Online Only Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7583415/
https://ncbi.nlm.nih.gov/pubmed/31641754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz1050
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires